R&D Sponsored Trials and tribulations of drug development What does it take to establish new treatments for rare diseases?
R&D Turning the NHS into a world-leading R&D platform Lord James O'Shaughnessy sets out the basis of his forthcoming independent review.
Oncology Better balance of cancer treatment efficacy and toxicity The FDA Oncology Center of Excellence announced its Project Optimus draft guidance in January.
News UK launches review of clinical trials amid worrying decline Review comes after drug industry saw a 41% decline in new trial starts between 2017 and 2021.
Patients Caring for rare: Celebrating Rare Disease Day 2023 Rare Disease Day is observed annually on what is considered the rarest day of the year.
News Protocol violations gut Pfizer’s Lyme disease shot study 50% of US patients in the VALOR study of VLA15 will be discontinued from the trial.
News Trump puts final piece in his MAHA puzzle with NIH nominee President-elect Donald Trump has chosen Stanford health economist Dr Jay Bhattacharya to lead the NIH
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
